{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:28:37Z","timestamp":1792664917845,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13555-020-00478-5","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T12:02:45Z","timestamp":1611057765000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Lessons Learned from the First Decade of Laser-Assisted Drug Delivery"],"prefix":"10.1007","volume":"11","author":[{"given":"Tamara","family":"Searle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0684-4322","authenticated-orcid":false,"given":"Firas","family":"Al-Niaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"478_CR1","doi-asserted-by":"crossref","unstructured":"Alegre-S\u00e1nchez A, Jim\u00e9nez-G\u00f3mez N, Boixeda P. Laser-assisted drug delivery. Actas Dermosifiliogr. 2018;109(10):858\u201367.","DOI":"10.1016\/j.ad.2018.07.008"},{"issue":"2","key":"478_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10103-015-1853-z","volume":"31","author":"FR Ali","year":"2016","unstructured":"Ali FR, Al-Niaimi F. Laser-assisted drug delivery in dermatology: from animal models to clinical practice. Laser Med Sci. 2016;31(2):373\u201381.","journal-title":"Laser Med Sci"},{"key":"478_CR3","doi-asserted-by":"publisher","first-page":"024018","DOI":"10.1117\/1.3103316","volume":"14","author":"OF Stumpp","year":"2009","unstructured":"Stumpp OF, Bedi VP, Wyatt D, et al. In vivo confocal imaging of epidermal cell migration and dermal changes post nonablative fractional resurfacing: study of the wound healing process with corroborated histopathologic evidence. J Biomed Opt. 2009;14:024018.","journal-title":"J Biomed Opt"},{"key":"478_CR4","doi-asserted-by":"crossref","unstructured":"Waibel JS, Rudnick A, Shagalov DR, Nicolazzo DM. Update of ablative fractionated lasers to enhance cutaneous topical drug delivery. Adv Ther. 2017;34(8):1840\u20139.","DOI":"10.1007\/s12325-017-0516-9"},{"key":"478_CR5","doi-asserted-by":"crossref","unstructured":"Ali FR, Wlodek C, Lear JT. The role of ingenol mebutate in the treatment of actinic keratoses. Dermatol Ther. 2012;2:8.","DOI":"10.1007\/s13555-012-0008-4"},{"key":"478_CR6","doi-asserted-by":"crossref","unstructured":"Wlodek C, Ali FR, Lear JT. Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients. Biomed Res Int. 2013:349526.","DOI":"10.1155\/2013\/349526"},{"key":"478_CR7","doi-asserted-by":"crossref","unstructured":"Erlendsson AM, Olesen UH, Haedersdal M, Rossi AM. Ablative fractional laser-assisted treatments for keratinocyte carcinomas and its precursors\u2014clinical review and future perspectives. Adv Drug Deliv Rev. 2020;153:185\u201394. (S0169-409X(20)30003-X)","DOI":"10.1016\/j.addr.2020.01.001"},{"key":"478_CR8","doi-asserted-by":"crossref","unstructured":"Karmisholt KE, Haedersdal M. Ablative fractional laser intensifies treatment outcome of scalp actinic keratoses with ingenol mebutate: a case report. J Eur Acad Dermatol. 2016;30(5):854\u20135.","DOI":"10.1111\/jdv.13021"},{"key":"478_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/bjd.12507","volume":"169","author":"P Helsing","year":"2013","unstructured":"Helsing P, Togsverd-Bo K, Veier\u00f8d MB, et al. Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands. Br J Dermatol. 2013;169:1087\u201392.","journal-title":"Br J Dermatol."},{"key":"478_CR10","doi-asserted-by":"crossref","unstructured":"Song HS, Jung S-E, Jang YH, et al. Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis. Photodermatol Photoimmunol Photomed. 2015;31(6):296\u2013301.","DOI":"10.1111\/phpp.12184"},{"key":"478_CR11","doi-asserted-by":"crossref","unstructured":"Kalil CL, Reinehr CP, de Mattos ML, Bakos RM. Combination therapies: laser-assisted delivery of 5-fluorouracil. Dermatol Surg. 2019;45(3):485\u20137.","DOI":"10.1097\/DSS.0000000000001578"},{"key":"478_CR12","doi-asserted-by":"crossref","unstructured":"Micali G, Lacarrubba F, Nasca MR. Reply to: \u201cLaser assisted drug delivery: enhanced response to ingenolmebutate after ablative fractional laser treatment.\u201d J Am Acad Dermatol. 2015;72(2):365\u20136.","DOI":"10.1016\/j.jaad.2014.10.024"},{"key":"478_CR13","doi-asserted-by":"crossref","unstructured":"Kim SK, Park JY, Song HS, Kim YS, Kim YC. Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease. Ann Dermatol. 2013;25(3):335\u20139.","DOI":"10.5021\/ad.2013.25.3.335"},{"key":"478_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bjd.12627","volume":"170","author":"DY Ko","year":"2014","unstructured":"Ko DY, Kim KH, Song KH. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol. 2014;170:165\u201372.","journal-title":"Br J Dermatol."},{"key":"478_CR15","doi-asserted-by":"crossref","unstructured":"Nguyen BT, Gan SD, Konnikov N, Liang CA. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil. J Am Acad Dermatol. 2015;72:558\u201360.","DOI":"10.1016\/j.jaad.2014.11.033"},{"key":"478_CR16","doi-asserted-by":"crossref","unstructured":"Telfer NR, Colver GB, Morton CA. British Association of Dermatologists guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159:35\u201348.","DOI":"10.1111\/j.1365-2133.2008.08666.x"},{"key":"478_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10103-011-1041-8","volume":"27","author":"M Haedersdal","year":"2012","unstructured":"Haedersdal M, Togsverd-Bo K, Paasch U. Case reports on the potential of fractional laser-assisted photodynamic therapy for basal cell carcinomas. Lasers Med Sci. 2012;27:1091\u20133.","journal-title":"Lasers Med Sci"},{"key":"478_CR18","doi-asserted-by":"crossref","unstructured":"Lippert J, Smucler R, Vlk M. Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatol Surg. 2013;39:1202\u20138.","DOI":"10.1111\/dsu.12242"},{"key":"478_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/bjd.13166","volume":"172","author":"CS Haak","year":"2015","unstructured":"Haak CS, Togsverd-Bo K, Thaysen-Petersen D, et al. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas\u2014a randomized clinical trial. Br J Dermatol. 2015;172:215\u201322.","journal-title":"Br J Dermatol"},{"key":"478_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bjd.13542","volume":"173","author":"SH Choi","year":"2015","unstructured":"Choi SH, Kim KH, Song KH. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial. Br J Dermatol. 2015;173:184\u201391.","journal-title":"Br J Dermatol"},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1601-0825.2004.01004.x","volume":"10","author":"A Markopoulos","year":"2004","unstructured":"Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis. 2004;10:212\u20136.","journal-title":"Oral Dis"},{"key":"478_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ejpb.2012.11.018","volume":"84","author":"YG Bachhav","year":"2013","unstructured":"Bachhav YG, Heinrich A, Kalia YN. Controlled intra- and transdermal protein delivery using a minimally invasive erbium:YAG fractional laser ablation technology. Eur J Pharm Biopharm. 2013;84:355\u201364.","journal-title":"Eur J Pharm Biopharm"},{"key":"478_CR23","doi-asserted-by":"crossref","unstructured":"Forbat E, Al-Niaimi F, Ali FR. The emerging importance of tranexamic acid in dermatology. Clin Exp Dermatol. 2020;45(4):445\u20139.","DOI":"10.1111\/ced.14115"},{"issue":"9","key":"478_CR24","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s10103-020-03045-8","volume":"35","author":"R Wanitphakdeedecha","year":"2020","unstructured":"Wanitphakdeedecha R, Sy-Alvarado F, Patthamalai P, Techapichetvanich T, Eimpunth S, Manuskiatti W. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study. Lasers Med Sci. 2020;35(9):2015\u201321.","journal-title":"Lasers Med Sci"},{"issue":"1","key":"478_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/lsm.23032","volume":"51","author":"SO Tawfic","year":"2019","unstructured":"Tawfic SO, Abdel Halim DM, Albarbary A, Abdelhady M. Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers Surg Med. 2019;51(1):27\u201333.","journal-title":"Lasers Surg Med"},{"key":"478_CR26","doi-asserted-by":"crossref","unstructured":"Mekawy KM, Sadek A, Seddeik Abdel\u2010Hameed AK. Micro\u2010needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split\u2010face study. J Cosmet Dermatol. 2020 (Epub ahead of print).","DOI":"10.1111\/jocd.13537"},{"key":"478_CR27","unstructured":"Nourmohammadi Abadchi S, Fatemi Naeini F, Beheshtian E. Combination of hydroquinone and fractional CO2 laser versus hydroquinone monotherapy in melasma treatment: a randomized, single-blinded, split-face. Clin Trial Ind J Dermatol. 2019;64(2):129\u201335."},{"key":"478_CR28","doi-asserted-by":"crossref","unstructured":"Badawi AM, Osman MA. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol. 2018;11:13\u201320.","DOI":"10.2147\/CCID.S147413"},{"key":"478_CR29","doi-asserted-by":"crossref","unstructured":"Mohamed HAR, Nasif GA, Abdel-Azim ES, Ahmed MAF. Comparative study of fractional erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol. 2019;18(2):517\u201323.","DOI":"10.1111\/jocd.12751"},{"key":"478_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10103-007-0452-z","volume":"22","author":"W-R Lee","year":"2007","unstructured":"Lee W-R, Shen S-C, Fang C-L, et al. Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics. Lasers Med Sci. 2007;22:271\u20138.","journal-title":"Lasers Med Sci"},{"key":"478_CR31","doi-asserted-by":"crossref","unstructured":"Singer AJ, Weeks R, Regev R. Laser-assisted anesthesia reduces the pain of venous cannulation in children and adults: a randomized controlled trial. Acad Emerg Med. 2006;13:623\u20138.","DOI":"10.1197\/j.aem.2006.01.016"},{"issue":"2","key":"478_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/lsm.22376","volume":"48","author":"AA Meesters","year":"2015","unstructured":"Meesters AA, Bakker MM, de Rie MA, Wolkerstorfer A. Fractional CO2 laser assisted delivery of topical anesthetics: a randomized controlled pilot study. Lasers Surg Med. 2015;48(2):208\u201311.","journal-title":"Lasers Surg Med"},{"key":"478_CR33","doi-asserted-by":"crossref","unstructured":"Yun PL, Tachihara R, Anderson RR. Efficacy of erbium:yttrium\u2013aluminum\u2013garnet laser-assisted delivery of topical anesthetic. J Am Acad Dermatol. 2002;47:542\u20137.","DOI":"10.1067\/mjd.2002.124819"},{"key":"478_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/lsm.22055","volume":"44","author":"L Qu","year":"2012","unstructured":"Qu L, Liu A, Zhou L, et al. Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser. Lasers Surg Med. 2012;44:517\u201324.","journal-title":"Lasers Surg Med"},{"key":"478_CR35","doi-asserted-by":"crossref","unstructured":"Ali FR, Forbat E, Al-Niaimi F. Laser treatment of keloid scars. Dermatol Surg. 2017;43(2):318.","DOI":"10.1097\/DSS.0000000000000995"},{"key":"478_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/lsm.22120","volume":"45","author":"JS Waibel","year":"2013","unstructured":"Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med. 2013;45:135\u201340.","journal-title":"Lasers Surg Med"},{"key":"478_CR37","doi-asserted-by":"crossref","unstructured":"Waibel JS, Wulkan AJ, Rudnick A, Daoud A. Treatment of hypertrophic scars using laser-assisted corticosteroid versus laser-assisted 5-fluorouracil delivery. Dermatol Surg. 2019;45(3):423\u201330.","DOI":"10.1097\/DSS.0000000000001678"},{"issue":"3","key":"478_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/lsm.22448","volume":"48","author":"JS Waibel","year":"2016","unstructured":"Waibel JS, Mi QS, Ozog D, et al. Laser-assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression. Lasers Surg Med. 2016;48(3):238\u201344.","journal-title":"Lasers Surg Med"},{"key":"478_CR39","doi-asserted-by":"crossref","unstructured":"Cavali\u00e9 M, Sillard L, Montaudi\u00e9 H, et al. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther. 2015;28:74\u20138.","DOI":"10.1111\/dth.12187"},{"key":"478_CR40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10103-017-2154-5","volume":"32","author":"JH Park","year":"2017","unstructured":"Park JH, Chun JY, Lee JH. Laser-assisted topical corticosteroid delivery for the treatment of keloids. Lasers Med Sci. 2017;32:601\u20138.","journal-title":"Lasers Med Sci"},{"issue":"9","key":"478_CR41","first-page":"925","volume":"16","author":"E Kraeva","year":"2017","unstructured":"Kraeva E, Ho D, Jagdeo J. Successful treatment of keloid with fractionated carbon dioxide (CO2) laser and laser-assisted drug delivery of triamcinolone acetonide ointment in an African-American man. J Drugs Dermatol. 2017;16(9):925\u20137.","journal-title":"J Drugs Dermatol"},{"key":"478_CR42","unstructured":"Rkein A, Ozog D, Waibel JS. Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-l-lactic acid. Dermatol Surg. 2014;40:624\u201331."},{"key":"478_CR43","doi-asserted-by":"crossref","unstructured":"Trelles MA, Lecl\u00e8re FM, Mart\u00ednez-Carpio PA. Fractional carbon dioxide laser and acoustic-pressure ultrasound for transepidermal delivery of cosmeceuticals: a novel method of facial rejuvenation. Aesthetic Plast Surg. 2013;37:965\u201372.","DOI":"10.1007\/s00266-013-0176-3"},{"key":"478_CR44","doi-asserted-by":"crossref","unstructured":"Mahmoud BH, Burnett C, Ozog D. Prospective randomized controlled study to determine the effect of topical application of botulinum toxin A for crow\u2019s feet after treatment with ablative fractional CO2 laser. Dermatol Surg. 2015;41:S75\u201381.","DOI":"10.1097\/01.DSS.0000452642.83894.ab"},{"key":"478_CR45","doi-asserted-by":"crossref","unstructured":"Brandt F, O\u2019Connell C, Cazzaniga A, Waugh JM. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Dermatol Surg. 2010;36:2111\u20138.","DOI":"10.1111\/j.1524-4725.2010.01711.x"},{"issue":"7\u20138","key":"478_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/14764172.2017.1418516","volume":"20","author":"AC Bertin","year":"2018","unstructured":"Bertin AC, Vilarinho A, Junqueira AL. Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss. J Cosmet Laser Ther. 2018;20(7\u20138):391\u20134.","journal-title":"J Cosmet Laser Ther"},{"key":"478_CR47","doi-asserted-by":"crossref","unstructured":"Cohen PR. Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma\u2014with or without concurrent bimatoprost and\/or minoxidil. Dermatol Online J. 2019;25(2).","DOI":"10.5070\/D3252042885"},{"key":"478_CR48","doi-asserted-by":"crossref","unstructured":"Majid I, Jeelani S, Imran S. Fractional carbon dioxide laser in combination with topical corticosteroid application in resistant alopecia areata: a case series. J Cutan Aesthet Surg. 2018;11(4):217\u201321.","DOI":"10.4103\/JCAS.JCAS_96_18"},{"issue":"1","key":"478_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15171\/jlms.2020.06","volume":"11","author":"M Salah","year":"2020","unstructured":"Salah M, Samy N, Fawzy MM, Farrag AR, Shehata H, Hany A. The effect of the fractional carbon dioxide laser on improving minoxidil delivery for the treatment of androgenetic alopecia. J Lasers Med Sci. 2020;11(1):29\u201336.","journal-title":"J Lasers Med Sci"},{"issue":"4","key":"478_CR50","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10103-018-2457-1","volume":"33","author":"RM Sobhi","year":"2018","unstructured":"Sobhi RM, Sharaoui I, El Nabarawy EA, Esmail RS, Hegazy RA, Aref DH. Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis. Lasers Med Sci. 2018;33(4):909\u201316.","journal-title":"Lasers Med Sci"},{"key":"478_CR51","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1586\/14760584.2013.844070","volume":"12","author":"X Chen","year":"2013","unstructured":"Chen X, Wang J, Shah D, Wu MX. An update on the use of laser technology in skin vaccination. Expert Rev Vaccines. 2013;12:1313\u201323.","journal-title":"Expert Rev Vaccines"},{"key":"478_CR52","doi-asserted-by":"crossref","unstructured":"Ma G, Wu P, Lin X, et al. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study. Pediatr Dermatol. 2014;31:286\u201391.","DOI":"10.1111\/pde.12299"},{"key":"478_CR53","doi-asserted-by":"crossref","unstructured":"Sun L, Wang C, Cao Y, et al. Fractional 2940-nm Er:YAG laser-assisted drug delivery of timolol maleate for the treatment of deep infantile hemangioma. J Dermatol Treat. 2020;22:1\u20137.","DOI":"10.1080\/09546634.2020.1729330"},{"key":"478_CR54","doi-asserted-by":"crossref","unstructured":"Yoo KH, Kim BJ, Kim MN. Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: a pilot study. Dermatol Surg. 2009;35:1927\u201332.","DOI":"10.1111\/j.1524-4725.2009.01307.x"},{"issue":"7","key":"478_CR55","first-page":"663","volume":"18","author":"M Coates","year":"2019","unstructured":"Coates M, Patel J, Powers C, Burton C. Laser-assisted delivery of topical cidofovir in the treatment of plantar warts. J Drugs Dermatol. 2019;18(7):663\u20135.","journal-title":"J Drugs Dermatol"},{"key":"478_CR56","doi-asserted-by":"crossref","unstructured":"Junsuwan N, Manuskiatti W, Phothong W, Wanitphakdeedecha R. Fractional CO2 laser-assisted botulinum toxin type A delivery for the treatment of primary palmar hyperhidrosis. Lasers Med Sci. 2020 (Epub ahead of print).","DOI":"10.1007\/s10103-020-03064-5"},{"key":"478_CR57","doi-asserted-by":"crossref","unstructured":"Zaleski-Larsen LA, Fabi SG. Laser-assisted drug delivery. Dermatol Surg. 2016;42(8):919\u201331.","DOI":"10.1097\/DSS.0000000000000556"},{"issue":"1","key":"478_CR58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/lsm.22769","volume":"50","author":"O Ibrahim","year":"2018","unstructured":"Ibrahim O, Wenande E, Hogan S, Arndt KA, Haedersdal M, Dover JS. Challenges to laser-assisted drug delivery: applying theory to clinical practice. Lasers Surg Med. 2018;50(1):20\u20137.","journal-title":"Lasers Surg Med"},{"key":"478_CR59","doi-asserted-by":"crossref","unstructured":"Haedersdal M, Erlendsson AM, Paasch U, Anderson RR. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol. 2016;74(5):981\u20131004.","DOI":"10.1016\/j.jaad.2015.12.008"},{"key":"478_CR60","doi-asserted-by":"crossref","unstructured":"Wenande E, Erlendsson AM, Haedersdal M. Opportunities for laser-assisted drug delivery in the treatment of cutaneous disorders. Semin Cutan Med Surg. 2017;36(4):192\u2013201.","DOI":"10.12788\/j.sder.2017.046"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13555-020-00478-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T05:22:14Z","timestamp":1670822534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-020-00478-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00478-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"8 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}